Introduction:It is important to determine the relation among the various lesions in patients presenting with multiple malignant lung tumors to define the best treatment approach. A better understanding of the molecular alterations present in the different lesions may help in defining this relation.Methods:We performed a detailed molecular analysis of several tumor specimens obtained from three patients presenting with multiple lung lesions. Tumor specimens were analyzed for epidermal growth factor receptor (EGFR) and k-ras mutations by direct DNA sequencing. In addition, a genome-wide chromosomal copy number analysis was performed on DNA extracted from the various lesions using array-based comparative genomic hybridization.Results:In one ca...
Lung cancer is a highly aggressive neoplasm which is reflected by a multitude of genetic aberrations...
Our understanding of genomic heterogeneity in lung cancer is largely based on the analysis of early-...
Background: Lung cancer is the world's leading cause of cancer mortality. The main factors contribu...
Introduction:It is important to determine the relation among the various lesions in patients present...
The prevalence of multiple lung cancers has been increasing recently. Molecular analysis of epiderma...
Patients with a primary cancer in the lung or in the upper aerodigestive tract have an increased ris...
BACKGROUND: Lung cancer is the most common cause of cancer death in the United States. Multiple anat...
Discrimination of multifocal primary lung cancers from lung metastases is crucial to allow for an ap...
Background: Epidermal growth factor receptor mutations are predictive of the success of EGFR tyrosin...
Background: Since multiple lung cancer treatment strategies differ, it is essential for clinicians t...
Activated epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KR...
Background: Epidermal growth factor receptor mutations are predictive of the success of EGFR tyrosin...
Multiple tumors in patients are frequently diagnosed, either synchronous or metachronous. The distin...
Introduction: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutation...
Introduction: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutation...
Lung cancer is a highly aggressive neoplasm which is reflected by a multitude of genetic aberrations...
Our understanding of genomic heterogeneity in lung cancer is largely based on the analysis of early-...
Background: Lung cancer is the world's leading cause of cancer mortality. The main factors contribu...
Introduction:It is important to determine the relation among the various lesions in patients present...
The prevalence of multiple lung cancers has been increasing recently. Molecular analysis of epiderma...
Patients with a primary cancer in the lung or in the upper aerodigestive tract have an increased ris...
BACKGROUND: Lung cancer is the most common cause of cancer death in the United States. Multiple anat...
Discrimination of multifocal primary lung cancers from lung metastases is crucial to allow for an ap...
Background: Epidermal growth factor receptor mutations are predictive of the success of EGFR tyrosin...
Background: Since multiple lung cancer treatment strategies differ, it is essential for clinicians t...
Activated epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KR...
Background: Epidermal growth factor receptor mutations are predictive of the success of EGFR tyrosin...
Multiple tumors in patients are frequently diagnosed, either synchronous or metachronous. The distin...
Introduction: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutation...
Introduction: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutation...
Lung cancer is a highly aggressive neoplasm which is reflected by a multitude of genetic aberrations...
Our understanding of genomic heterogeneity in lung cancer is largely based on the analysis of early-...
Background: Lung cancer is the world's leading cause of cancer mortality. The main factors contribu...